A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...

Rheumatoid arthritis and spondyloarthritis are long-lasting inflammatory diseases that gradually wear down joints. While ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Certolizumab Pegol is indicated for the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic ...

Lupin partners with Zentiva Group for global commercialisation of Certolizumab Pegol biosimilar, sharing profits and investments.

When psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.

Articularis Rheumatology Specialists (ARS), a division of Articularis Healthcare Group (AHG), is pleased to announce the ...